Tom Chen in

Tom Chen

Login to view DISC.
Senior Director, Head of Drug Substance and MSAT at Dianthus Therapeutics, Inc.
📍 Cambridge, Massachusetts, United States

Tom Chen is a seasoned leader with over 20 years of experience in drug development and protein biochemistry. As a Senior Director at Dianthus Therapeutics, he heads the Drug Substance and CMC teams for biologic products, leveraging his PhD from the Max Planck Institute.

His research publications focus on the molecular level of disease, including how certain proteins can interfere with cellular processes, which is relevant to understanding neurodegenerative disorders.

Read the full overview →
Experience
15 Years
Current Role
Senior Director, Head of Drug Substance and MSAT
Job Level
Senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Tom shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Tom cares about

Biologics Development
Leads the development of biologics, including monoclonal antibodies, bispecifics, and fusion proteins at Dianthus Therapeutics.
CMC Strategy
He is responsible for designing and executing phase-appropriate CMC strategies for pipeline molecules, a key part of his leadership role.
+6 more topics Login to view topics
Career

Work history

12-2024
Senior Director, Head of Drug Substance and MSAT
Dianthus Therapeutics, Inc.
5-2022 - 12-2024
Director, Drug Substance and Early Development CMC Lead
Dianthus Therapeutics, Inc.
2021 - 4-2022
Director, Analytical and Formulation Development - CMC Lead
Dianthus Therapeutics, Inc.
2021 - 2021
Director, Analytical and Pharmaceutical Science
Eagle Pharmaceuticals, Inc.
2019 - 2021
Associate Director of Analytical Development
STC Biologics Inc
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Ph
Max Planck Society
PhD
Ludwig-Maximilians-Universität München
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Dianthus Therapeutics, Inc. Employees

Explore more public profiles from related professionals.

Ryan Savitz
Ryan Savitz
Chief Financial Officer & Chief Business Officer
Dianthus Therapeutics, Inc.

More profiles

Discover additional public profiles from our index.

Holly Spiers
Holly Spiers
Marketing and Communications Director
SafeRec
 David Martens
David Martens
Head of Product Security
Barco
 Raghavendra Yadavalli, PhD
Raghavendra Yadavalli, PhD
Research Scientist II
REGENXBIO
 Temesghen Starr
Temesghen Starr
Assistant Vice President of Athletics Growth & Revenue Generation
Delaware State University
Unlock the full playbookSee exactly how to sell to Tom. Free, 10 seconds.